For decades, the cannabis industry has struggled to erase a deep-rooted stigma, punctuated by various anti-cannabis propaganda campaigns, most notably by films, such as Reefer Madness. The complex science, innovative research, and health benefits of this plant are often over-shadowed by false narratives driven by fear, politics, and competing industry profits.
It’s time for that narrative to change.
We are excited to announce that Medicinal Genomics will be featured in an upcoming television series called High Science®, a production created to highlight various facets of the cannabis industry and the struggles in its quest for legalization. The series will be produced by an acclaimed team of seasoned television executives, including David McKillop, the former GM of A&E, responsible for the multi-Emmy® award-winning documentaries 102 Minutes That Changed America and Gettysburg, along with other notable television productions.
MGC scientists will dive into cannabis genetics, safety testing, regulation challenges, and much more. You’ll also get an in-depth look into CannMed 2022, one of the industry’s leading cannabis science conferences, as film crews tape behind-the-scenes and during the conference, interviewing speakers, sponsors, and those who make it all happen.
Medicinal Genomics has never been a company to take a conventional path. We are an emerging biotech company, steadfast in our commitment to our clients, scientific research, transparency, and cannabis education. Our partnership with High Science® allows us to reach a broader audience, eliminate the stigma, support legalization, while continuing to help patients in need.
We are looking forward to a wild ride over the next few months, so stay tuned!